Given the NMJ instability and evidence of muscle denervation in PD,27, 29 interventions targeting components of the NMJ, including agrin, lipoprotein receptor‐related protein 4, muscle‐specific kinase, and rapsyn, have potential to restore NMJ structure and function. Here, AGRN is linked to Parkinson disease.